PBYI — PUMA BIOTECHNOLOGY INC

Ownership history in KENNEDY CAPITAL MANAGEMENT LLC  ·  9 quarters on record

This page tracks every 13F SEC filing in which KENNEDY CAPITAL MANAGEMENT LLC reported a position in PUMA BIOTECHNOLOGY INC (PBYI). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.14% (2019 Q3)
Avg. % of fund
0.07%
First filed
2014 Q3
Last filed
2025 Q4
Quarters held
9
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 868,315 +685 +0.1% 0.11% $5.2M $5.95
2025 Q3 REDUCED 867,630 -119,371 -12.1% 0.10% $4.6M $5.31
2025 Q2 ADDED 987,001 +75,878 +8.3% 0.08% $3.4M $3.43
2025 Q1 ADDED 911,123 +101,748 +12.6% 0.06% $2.7M $2.96
5 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    PBYI price (monthly, adj. close)

Other funds also holding PBYI

As of 2025 Q4 — sorted by position size

ACORN CAPITAL ADVISORS, LLC 8.33% GLOBEFLEX CAPITAL L P 3Y 7Y 0.41% Verdad Advisers, LP 3Y 0.38% VIRTUS ADVISERS, LLC 3Y 7Y 0.13% C2C Wealth Management, LLC 3Y 0.12% BRIDGEWAY CAPITAL MANAGEMENT, LLC 3Y 7Y 0.1% Round Rock Advisors LLC 3Y 0.09% EntryPoint Capital, LLC 0.08% RITHOLTZ WEALTH MANAGEMENT 3Y 7Y 0.08% Baron Wealth Management LLC 0.06%
← Back to KENNEDY CAPITAL MANAGEMENT LLC Holdings